The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-Fluoro-phenyl)-2-(2-fluoro-phenyl)-2-phenyl-acetamide ID: ALA42205
PubChem CID: 9966986
Max Phase: Preclinical
Molecular Formula: C20H15F2NO
Molecular Weight: 323.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Synonyms: ICA-15451 | CHEMBL42205|(2-fluorophenyl)-(4-fluorophenyl)phenylacetamide|SCHEMBL1443821|UFALWTGZIJAUPP-UHFFFAOYSA-N|BDBM50099566|ICA-15451|PD177942|(2-fluorophenyl)-(4 fluorophenyl)phenylacetamide|2-(4-Fluoro-phenyl)-2-(2-fluoro-phenyl)-2-phenyl-acetamide
Canonical SMILES: NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccccc1F
Standard InChI: InChI=1S/C20H15F2NO/c21-16-12-10-15(11-13-16)20(19(23)24,14-6-2-1-3-7-14)17-8-4-5-9-18(17)22/h1-13H,(H2,23,24)
Standard InChI Key: UFALWTGZIJAUPP-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
1.6625 -4.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4542 -4.6375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8792 -4.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2750 -3.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2667 -4.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6542 -5.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8667 -5.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1000 -3.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0542 -4.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2792 -4.6375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5000 -2.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4417 -5.5292 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.7042 -2.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6667 -3.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1125 -2.2167 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.7042 -3.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5125 -4.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3625 -5.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9375 -5.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0750 -3.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3542 -6.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6875 -3.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9292 -6.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6417 -6.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 1 1 0
5 3 1 0
6 1 1 0
7 2 2 0
8 4 1 0
9 4 2 0
10 2 1 0
11 14 2 0
12 5 1 0
13 8 2 0
14 9 1 0
15 11 1 0
16 3 2 0
17 5 2 0
18 6 1 0
19 6 2 0
20 16 1 0
21 18 2 0
22 20 2 0
23 19 1 0
24 23 2 0
13 11 1 0
24 21 1 0
17 22 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 323.34Molecular Weight (Monoisotopic): 323.1122AlogP: 3.78#Rotatable Bonds: 4Polar Surface Area: 43.09Molecular Species: NEUTRALHBA: 1HBD: 1#RO5 Violations: ┄HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.46CX LogD: 4.46Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.73Np Likeness Score: -0.95
References 1. Coghlan MJ, Carroll WA, Gopalakrishnan M.. (2001) Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress., 44 (11): [PMID:11356099 ] [10.1021/jm000484+ ] 2. McNaughton-Smith GA, Burns JF, Stocker JW, Rigdon GC, Creech C, Arrington S, Shelton T, de Franceschi L.. (2008) Novel inhibitors of the Gardos channel for the treatment of sickle cell disease., 51 (4): [PMID:18232633 ] [10.1021/jm070663s ]